A Study to Evaluate the Efficacy and Safety of ENERGI-F705 Tablets for Parkinson's Disease
Clinical trial NCT07647614 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07647614
- Sponsor
- Energenesis Biomedical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-12-01
- Primary completion
- 2030-01-01
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.